Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as markers of stable ischemic heart disease in diabetic patients: An observational study.

MLA

Joshi, Amey, et al. “Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio as Markers of Stable Ischemic Heart Disease in Diabetic Patients: An Observational Study.” Medicine, vol. 102, no. 5, Feb. 2023, p. e32735. EBSCOhost, https://doi.org/10.1097/MD.0000000000032735.

APA

Joshi, A., Bhambhani, A., Barure, R., Gonuguntla, S., Sarathi, V., Attia, A. M., Shrestha, A. B., & Jaiswal, V. (2023). Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as markers of stable ischemic heart disease in diabetic patients: An observational study. Medicine, 102(5), e32735. https://doi.org/10.1097/MD.0000000000032735

Chicago

Joshi, Amey, Anupam Bhambhani, Ramdas Barure, Samhitha Gonuguntla, Vijaya Sarathi, Abdelrahman M Attia, Abhigan Babu Shrestha, and Vikash Jaiswal. 2023. “Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio as Markers of Stable Ischemic Heart Disease in Diabetic Patients: An Observational Study.” Medicine 102 (5): e32735. doi:10.1097/MD.0000000000032735.